Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (14 ops.)
Latest filing published 16 Sept 2024 for Century Therapeutics, Inc., €6,912. Read the official filing
Filing timeline
BuySaleDaphne Quimi
Insider track record
Disclosed buys
2
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Daphne Quimi: trading record in brief
Daphne Quimi (finance chief) discloses dealings in 3 companies, chiefly Amicus Therapeutics, Inc., Amylyx Pharmaceuticals, Inc. and Century Therapeutics, Inc. The record holds 56 filings, for trades running from 4 January 2016 to 12 September 2024.
The open-market side counts 2 purchases for €12k alongside 14 sales for €1.0M. Taken together, the sales exceed the purchases by €1.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 23 share grants and 17 option exercises. 2024 to date brings 2 purchases and no sales.
Most recently, on 16 September 2024, the filings show an open-market purchase worth €6,912 in Century Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Daphne Quimi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
5,000 shares@ US$1.5314100.0% of flowCommon StockSEC:0001062993-24-016641:0
Canonical exit: 11 Dec 2024 (T+90)
2,750 shares@ US$1.885100.0% of flowCommon StockSEC:0000950170-24-061294:0
Canonical exit: 12 Aug 2024 (T+90)
5,000 shares@ US$12.48898.9% of flowCommon StockSEC:0001209191-23-004080:0
58,824 shares0Common StockSEC:0001209191-23-003306:0
3,884 shares@ US$12.036.9% of flowCommon StockSEC:0001209191-23-002400:0
15,165 shares@ US$12.2126.8% of flowCommon StockSEC:0001209191-23-001394:0
4,397 shares@ US$11.28517.7% of flowCommon StockSEC:0001209191-22-048797:0
5,798 shares@ US$12.0010.5% of flowCommon StockSEC:0001209191-22-045060:0
4,396 shares@ US$9.000.0008% mcap14.9% of flowCommon StockSEC:0001209191-22-038365:0
36,840 sharesCommon StockSEC:0001209191-22-003818:0
10,502 shares@ US$11.5519.9% of flowCommon StockSEC:0001209191-22-001205:0
25,000 sharesCommon stockSEC:0001209191-16-089833:0
9,311 sharesCommon stockSEC:0001209191-16-089833:1
13 of 13 declarations
